Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes. [electronic resource]
Producer: 20140908Description: 133-44 p. digitalISSN:- 1522-9653
- Alginates
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Benzoxazines -- pharmacology
- Cartilage, Articular -- metabolism
- Cell Death -- drug effects
- Cells, Cultured
- Chondrocytes -- drug effects
- Drug Evaluation, Preclinical -- methods
- Gene Expression Regulation -- drug effects
- Glucuronic Acid
- Hexuronic Acids
- Humans
- Interleukin-1beta -- antagonists & inhibitors
- Matrix Metalloproteinase 13 -- biosynthesis
- Matrix Metalloproteinase 3 -- biosynthesis
- Matrix Metalloproteinases -- biosynthesis
- Morpholines -- pharmacology
- Naphthalenes -- pharmacology
- Osteoarthritis, Knee -- metabolism
- Receptors, Cannabinoid -- metabolism
- Tissue Inhibitor of Metalloproteinase-1 -- biosynthesis
- Tissue Inhibitor of Metalloproteinase-2 -- biosynthesis
- Tissue Inhibitor of Metalloproteinases -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.